Alnylam Pharmaceuticals (NASDAQ:ALNY) Cut to “Hold” at StockNews.com
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. Other equities analysts have also recently issued research reports about the stock. Sanford C. Bernstein decreased their price objective on shares of Alnylam Pharmaceuticals from $314.00 to […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. Other equities analysts have also recently issued research reports about the stock. Sanford C. Bernstein decreased their price objective on shares of Alnylam Pharmaceuticals from $314.00 to […]
